Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
ESR Essentials: artificial intelligence in breast imaging—practice recommendations by the European Society of Breast Imaging
1
Zitationen
8
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) can enhance the diagnostic performance of breast cancer imaging and improve workflow optimization, potentially mitigating excessive radiologist workload and suboptimal diagnostic accuracy. AI can also boost imaging capabilities through individual risk prediction, molecular subtyping, and neoadjuvant therapy response predictions. Evidence demonstrates AI's potential across multiple modalities. The most robust data come from mammographic screening, where AI models improve diagnostic accuracy and optimize workflow, but rigorous post-market surveillance is required before any implementation strategy in this field. Commercial tools for digital breast tomosynthesis and ultrasound, potentially able to reduce interpretation time and improve accuracy, are also available, but post-implementation evaluation studies are likewise lacking. Besides basic tools for breast MRI with limited proven clinical benefit, AI applications for other modalities are not yet commercially available. Applications in contrast-enhanced mammography are still in the research stage, especially for radiomics-based molecular subtype classification. Applications of Large Language Models (LLMs) are in their infancy, and there are currently no clinical applications. Consequently, and despite their promise, all commercially available AI tools for breast imaging should currently still be regarded as techniques that, at best, aid radiologists in image evaluation. Their use is therefore optional, and the findings may always be overruled. KEY POINTS: AI systems improve diagnostic accuracy and efficiency of mammography screening, but long-term outcomes data are lacking. Commercial tools for digital breast tomosynthesis and ultrasound are available, but post-implementation evaluation studies are lacking. AI tools for breast imaging should still be regarded as a non-obligatory aid to radiologists for image interpretation.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.787 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.485 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.734 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.099 Zit.
Autoren
Institutionen
- Ente Ospedaliero Cantonale(CH)
- Istituto Imaging della Svizzera Italiana
- Università della Svizzera italiana(CH)
- Humanitas University(IT)
- IRCCS Humanitas Research Hospital(IT)
- Royal College of Surgeons in Ireland(IE)
- Beaumont Hospital(IE)
- University of Messina(IT)
- University of Naples Federico II(IT)
- Radboud University Nijmegen(NL)
- Radboud University Medical Center(NL)
- The Netherlands Cancer Institute(NL)
- Oncode Institute(NL)
- Columbia University(US)